
Fluoxetine hydrochloride is a premium-grade, high-purity, white-to-off-white crystalline powder carrying CAS number 59333-67-4. Refined under strict pharmaceutical quality compliance, this active pharmaceutical ingredient (API) exhibits exceptional performance in the development of selective serotonin reuptake inhibitors (SSRIs) and advanced neurological research. Therefore, it provides reliable stability in sensitive medicinal formulations and ensures consistent therapeutic activity. Consequently, it serves as an ideal core choice for specialized neuropsychiatric drug formulations and modern pharmaceutical synthesis processes globally.
Excellent thermal stability and outstanding biochemical affinity provide a distinct operational edge. This advantage is crucial when engineering modern high-performance neurological formulations. This active pharmaceutical solid operates by facilitating the systemic modification of targeted neurotransmitter pathways. Thus, it successfully enhances the therapeutic profiling of targeted pharmaceutical matrices. It supplies the exact chemical mechanisms required to induce rapid synthetic steps. As a consequence, it does this without altering raw mass density uniformity.
It assists formulation engineers in maintaining strict active concentration uniformity. This balance is critical across high-speed pharmaceutical synthesis operations and continuous filling lines. Hence, it mitigates trace impurity risks within automated volumetric dosing machinery. For instance, specialized production facilities incorporate this refined powder. It acts as a core active component in targeted neuropsychiatric management and specialized treatment cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean-room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule.
[Image of SSRI mechanism of action]
In addition to this, Zyntex coordinates climate-controlled logistics for manufacturing operations. This service supports advanced pharmaceutical synthesis centers globally. The compound maintains its refined molecular geometry under strict storage parameters. Therefore, it prevents temperature-induced degradation during automated mechanical blending steps. It advances contemporary drug engineering by providing a thoroughly analyzed, highly predictable raw material.
Simultaneously, it remains a critical standard for routine analytical validation testing loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial pharmaceutical batches and the analytical rigor of specialized laboratories.
This high-purity active compound delivers crucial technical value within these four primary sectors:
Primary API for SSRI-based medicinal formulations and treatments.
Standard reference material for serotonin reuptake studies.
Highly purified intermediate for customized pharmaceutical drug manufacturing.
Reference material for validating neurological active ingredient kinetics.
| Parameter | Standard Value |
|---|---|
| Product Name | Fluoxetine hydrochloride |
| Assay / Purity | Min 99.0% |
| Appearance | White crystalline powder |
| CAS Number | 59333-67-4 |
⚠️ IMPORTANT / Safety & Handling: Active Pharmaceutical Ingredient (API). Use only in specialized laboratory and production facilities. Avoid contact with eyes, skin, and respiratory tract. Review the Safety Data Sheet (SDS) for detailed protocols.